Revenue surged 52% year-over-year to $132 million in Q2 2026, with net income of $111 million driven by a $113 million gain from the lab products business sale. Testing services and digital solutions saw robust growth, and the company completed the acquisition of Naveris while maintaining a strong cash position.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.